203 related articles for article (PubMed ID: 24167104)
1. Neuropathic pain in patients with sickle cell disease.
Brandow AM; Farley RA; Panepinto JA
Pediatr Blood Cancer; 2014 Mar; 61(3):512-7. PubMed ID: 24167104
[TBL] [Abstract][Full Text] [Related]
2. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience.
Cregan M; Puri L; Kang G; Anghelescu D
Pediatr Blood Cancer; 2022 Apr; 69(4):e29583. PubMed ID: 35147289
[TBL] [Abstract][Full Text] [Related]
4. Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?
Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Pullum C; Schlaeger JM; Fillingim RB; Wilkie DJ
Pain Pract; 2016 Mar; 16(3):282-93. PubMed ID: 25581383
[TBL] [Abstract][Full Text] [Related]
5. Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
Antunes FD; Propheta VGS; Vasconcelos HA; Cipolotti R
Ann Hematol; 2017 Jul; 96(7):1121-1125. PubMed ID: 28361297
[TBL] [Abstract][Full Text] [Related]
6. Neuropathic pain in individuals with sickle cell disease.
Sharma D; Brandow AM
Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
[TBL] [Abstract][Full Text] [Related]
7. Screening for neuropathic pain in patients with sickle cell disease: is a single assessment scale sufficient?
Antunes FD; Silva Junior CL; Cerqueira KS; do Livramento Faro M; Cipolotti R
Orphanet J Rare Dis; 2019 May; 14(1):108. PubMed ID: 31088489
[TBL] [Abstract][Full Text] [Related]
8. Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease.
Powell-Roach K; Yao Y; Ezenwa MO; Schlaeger JM; Suarez ML; Molokie RE; Wang ZJ; Wilkie DJ
West J Nurs Res; 2020 Feb; 42(2):125-130. PubMed ID: 30900520
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain in sickle cell disease: measurement and management.
Glaros A; Brandow AM
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):553-561. PubMed ID: 33275730
[TBL] [Abstract][Full Text] [Related]
10. Neuropathic Pain and Sickle Cell Disease: a Review of Pharmacologic Management.
Orhurhu MS; Chu R; Claus L; Roberts J; Salisu B; Urits I; Orhurhu E; Viswanath O; Kaye AD; Kaye AJ; Orhurhu V
Curr Pain Headache Rep; 2020 Jul; 24(9):52. PubMed ID: 32705357
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life and neuropathic pain in sickle cell disease in Jamaica.
Bartlett R; Ramsay Z; Ali A; Grant J; Rankine-Mullings A; Gordon-Strachan G; Asnani M
Disabil Health J; 2021 Oct; 14(4):101107. PubMed ID: 33867318
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.
Wilkie DJ; Molokie R; Boyd-Seal D; Suarez ML; Kim YO; Zong S; Wittert H; Zhao Z; Saunthararajah Y; Wang ZJ
J Natl Med Assoc; 2010 Jan; 102(1):18-27. PubMed ID: 20158132
[TBL] [Abstract][Full Text] [Related]
14. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
[TBL] [Abstract][Full Text] [Related]
15. The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay.
Brandow AM; Farley RA; Dasgupta M; Hoffmann RG; Panepinto JA
J Pediatr Hematol Oncol; 2015 Jan; 37(1):10-5. PubMed ID: 25222053
[TBL] [Abstract][Full Text] [Related]
16. Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease.
Harris KM; Preiss L; Varughese T; Bauer A; Calhoun CL; Treadwell M; Masese R; Hankins JS; Hussain FA; Glassberg J; Melvin CL; Gibson R; King AA;
JAMA Netw Open; 2023 May; 6(5):e2314070. PubMed ID: 37200033
[TBL] [Abstract][Full Text] [Related]
17. Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.
Brandow AM; Farley RA; Panepinto JA
Pediatr Blood Cancer; 2015 Sep; 62(9):1501-11. PubMed ID: 25976161
[TBL] [Abstract][Full Text] [Related]
18. Avoiding Catch-22: validating the PainDETECT in a in a population of patients with chronic pain.
Timmerman H; Wolff AP; Bronkhorst EM; Wilder-Smith OHG; Schenkels MJ; van Dasselaar NT; Huygen FJPM; Steegers MAH; Vissers KCP
BMC Neurol; 2018 Jun; 18(1):91. PubMed ID: 29958535
[TBL] [Abstract][Full Text] [Related]
19. Neurobiological mechanisms of pain in sickle cell disease.
Wang ZJ; Wilkie DJ; Molokie R
Hematology Am Soc Hematol Educ Program; 2010; 2010():403-8. PubMed ID: 21239826
[TBL] [Abstract][Full Text] [Related]
20. Do We Pay Enough Attention to Neuropathic Pain in Knee Osteoarthritis Patients?
Golob M; Marković I; Zovko N; Šakić D; Gudelj-Gračanin A; Morović-Vergles J
Acta Clin Croat; 2018 Mar; 57(1):16-21. PubMed ID: 30256007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
